Hyperlipidemia

There are 897 papers on hyperlipidemia in aging research: 63 trials and 611 observational studies in people, 85 in animals, 3 in cells, 111 reviews. The newest story, Nov 10, 2026: “Gut bacterial product changes blood fat levels in mice”.

Disease

897 papers study it318 more mention it145 findings

106 new papers in 30 daysSee all 1,215 papers on hyperlipidemia

At a glance

Hyperlipidemia is linked with age-related macular degeneration in human studies, although a study of dry age-related macular degeneration finds no clear adjusted link. Cognitive associations point both ways: higher mild cognitive impairment risk in later life, but lower risk in a study of women. A rat study reports that hyperlipidemia induces cellular senescence in the cartilage endplate.

145 findings in 129 papers from 1983 to 2026, 33 of them since April 2026

“a lower rate of hyperlipidemia (32.0% vs 39.5%; OR 0.71; 95% CI, 0.63-0.80; P < .005).”
Prevalence of Systemic Comorbidities and Ocular Complications in Patients With Bilateral Retinal TelangiectasiaJournal of vitreoretinal diseases2026doi:10.1177/24741264261423313
  • Human trial63
  • Humans611
  • Animals85
  • Cells3
  • In silico4

Interventions

13

Bariatric-metabolic surgery combined with continuity of care

downin humans1−80% remission

1 study
  1. Bariatric-metabolic surgery combined with continuity of care is linked with lower hyperlipidemia in humans (patients with obesity and hyperlipidemia) (79.55% remission).

    “remission rates were 69.57 % for hypertension, 94.62 % for hyperuricemia, 80.00 % for type 2 diabetes mellitus, and 79.55 % for hyperlipidemia.”

    Humanspatients with obesity and hyperlipidemia12 months

    Effect of bariatric-metabolic surgery combined with continuity of care on the remission of metabolic diseases in patients with obesity

    Nutricion hospitalaria

More on Bariatric-metabolic surgery combined with continuity of care

Lorlatinib

upin humans1

1 study
  1. Lorlatinib is linked with hyperlipidemia in humans (ALK-rearranged NSCLC; despite rosuvastatin 40 mg) (Total cholesterol 270 to 411, LDL 170 to 303, triglycerides 162 to 264 mg/dL).

    “We present lorlatinib induced severe hyperlipidemia managed with triple-agent lipid-lowering therapy.”

    HumansALK-rearranged NSCLC; despite rosuvastatin 40 mgthree monthsfemalesn = 1

    Lorlatinib Induced Severe Refractory Hyperlipidemia: A Cardio-Oncology Challenge in ALK Positive NSCLC

    AHA Scientific Sessions 2026 abstract

More on Lorlatinib

High-fat diet

upin mice1

1 study
  1. High-fat diet induces hyperlipidemia in mice (B6C3F1 mice).

    “A temporary gain of body weight and hyperlipidemia were observed in mice fed the HFD.”

    AnimalsB6C3F1 micefour weeksmales

    Impact of a Short-Term High-Fat Diet on Lifespan and Tumorigenesis After Early-Life Exposure to Radiation

    Dose-response : a publication of International Hormesis Society

More on High-fat diet

Ganoderma lucidum

downin mice1

1 study
  1. Ganoderma lucidum decreases hyperlipidemia in ovariectomized mice.

    “GLP administration markedly lowered circulating TC and LDL‐C”

    Animalsin ovariectomized micepolysaccharidesplasma-serum

    Ganoderma lucidum polysaccharides improve liver metabolic disorders by modulating gut microbiota of ovariectomized mice

    International journal of molecular medicine

More on Ganoderma lucidum

Rosuvastatin

downin animals1

1 study
  1. Rosuvastatin decreases hyperlipidemia in vivo hyperlipidemia.

    “R-CD-CNs showed a more prominent effect compared to plain Rosuvastatin calcium and the disease control group.”

    Animalsin vivo hyperlipidemiananoparticles

    Enhancing solubility and therapeutic potential of rosuvastatin via β-cyclodextrin inclusion complex-loaded chitosan nanoparticles

    Pharmaceutical development and technology

More on Rosuvastatin

Statins

downin humans1

1 study
  1. Statins decrease hyperlipidemia in patients with non-dialysis-dependent CKD.

    “current clinical guidelines only recommend statin use for the treatment of hyperlipidemia in patients with non-dialysis-dependent CKD”

    Reviewin patients with non-dialysis-dependent CKD

    Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol

    Drugs

More on Statins

CD47 ASO

downin mice1

1 study
  1. CD47 ASO decreases hyperlipidemia in mice.

    “It also improved glucose tolerance, insulin sensitivity, and hyperlipidemia-key metabolic disturbances commonly associated with aging.”

    Animals25 μg/g10 weeksmales

    CD47 antisense oligonucleotide treatment improves glucose homeostasis and alleviates dyslipidemia in aged male mice

    Aging

More on CD47 ASO

Cucumis sativus

downin humans1

1 study
  1. Cucumis sativus decreases hyperlipidemia in humans.

    “Studies indicate that intake of citrus, cucumbers and grapes reduces hypertension, hyperlipidemia, skin problems and infections and improves the health of the cardiovascular and nervous systems.”

    Review

    Foods of the Mediterranean diet: citrus, cucumber and grape

    Journal of preventive medicine and hygiene

More on Cucumis sativus

Urolithin B

downin reviews1

1 study
  1. Urolithin B prevents hyperlipidemia.

    “According to several studies, Uro B prevents the development of hyperlipidemia, cardiovascular disease (CVD) and tumors due to its strong antioxidant and anti-inflammatory properties.”

    Review

    Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins

    Frontiers in pharmacology

More on Urolithin B

Active living-oriented zoning codes

no changein humans1

1 study
  1. Active living-oriented zoning codes were not clearly linked with hyperlipidemia in humans.

    “Little evidence was found that body mass index in youth, adults, or older adults or the odds of hyperlipidemia or hypertension in adults or older adults differed according to the strength of active living-oriented zoning.”

    Humans2012-2016

    Active living-oriented zoning codes and cardiometabolic conditions across the lifespan

    Translational behavioral medicine

More on Active living-oriented zoning codes

[nle27]ghrh-(1-29)-nh2

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 induces hyperlipidemia in humans.

    “The only adverse side-effect was transient hyperlipidemia, which resolved by the end of the study.”

    Human trial10 microg/kg nightlyresolved by the end of the study

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

More on [nle27]ghrh-(1-29)-nh2

All 13

Effects

8

Mortality

upin humans3

3 studies
  1. Hyperlipidemia is linked with higher mortality in humans (hyperlipidemia with diabetes mellitus) (from 2.79 to 17.24 per 100,000, AAPC 7.57 (95% CI: 6.28-9.19)).

    “AAMRs increased from 2.79 to 17.24, with an AAPC of 7.57 (95% CI: 6.28-9.19; p < 0.001).”

    Humanshyperlipidemia with diabetes mellitusn = 595,203

    Temporal trends in hyperlipidemia among adults with diabetes mellitus, 1999-2024: insights from the CDC WONDER Database

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  2. Hyperlipidemia is linked with higher mortality in humans (hypertensive patients with hyperlipidemia) (AAPC 9.11 (95% CI: 8.59 to 9.63)).

    “With an overall AAPC of 9.11 (95% CI: 8.59 to 9.63; p = <0.000001), the overall AAMR increased from 5.90 in 2000 to 34.90 in 2020.”

    Humanshypertensive patients with hyperlipidemia

    Longitudinal Trends and Disparities in Hypertension and Hyperlipidemia Related Mortality in the United States from 2000 to 2020

    AHA Scientific Sessions 2025 abstract

  3. Hyperlipidemia is linked with higher mortality in humans (associated with hyperlipidemia and diabetes) (AAPC: 8.11%, 95% CI: 7.59 to 9.07, p<0.000001).

    “Ultimately asignificantly escalating upsurge was observed from 10.24 in 2018 to 14.7 in 2020 (APC:19.43)(AAPC: 8.11%, 95% CI: 7.59 to 9.07, p<0.000001).”

    Humansassociated with hyperlipidemia and diabetes1999-2020

    SUN-600 The Dual Burden of Diabetes and Hyperlipidemia: Untangling Mortality Trends and Disparities Among Adults in The United States (1999-2020)

    ENDO 2025 abstract

Brain age gap

no changein humans1

1 study
  1. Hyperlipidemia was not clearly linked with brain age gap in humans (severe obesity; linear and robust regression models).

    “BMI, hypertension, and hyperlipidemia were not associated with BAG in either linear or robust models.”

    Humanssevere obesity; linear and robust regression modelsbrainn = 97

    Elevated HbA1c is associated with advanced brain age in severe obesity

    medRxiv : the preprint server for health sciencesPreprint

More on Brain age gap

Cellular senescence

upin rats1

1 study
  1. Hyperlipidemia induces cellular senescence in rat model.

    “HLP could induce ox-LDL, LOX-1, senescence and calcification markers high expression in EPC”

    Animalsin rat modelcartilage endplate

    Dysregulated lipid metabolism and intervertebral disc degeneration: the important role of ox-LDL/LOX-1 in endplate chondrocyte senescence and calcification

    Molecular medicine (Cambridge, Mass.)

More on Cellular senescence

Overall survival

upin humans1HR 0.741

1 study
  1. Hyperlipidemia is linked with better overall survival in middle-aged NSCLC patients (HR = 0.741, 95% CI: 0.566-0.971).

    “Hyperlipidemia may be a protective factor for survival in middle-aged group (HR = 0.741, 95% CI: 0.566-0.971, P = 0.030).”

    Humansin middle-aged NSCLC patients

    Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients

    Journal of geriatric cardiology : JGC

White matter hyperintensity markers

no changein humans1

1 study
  1. Hyperlipidemia was not clearly linked with white matter hyperintensity markers in humans (non-demented).

    “Body mass index or hyperlipidemia showed no association with WMH markers.”

    Humansnon-dementedbrainn = 155

    Different cardiovascular risk factors are related to distinct white matter hyperintensity MRI phenotypes in older adults

    NeuroImage. Clinical

More on White matter hyperintensity markers

Dry age-related macular degeneration

no changein humans1

1 study
  1. Hyperlipidemia was not clearly linked with dry age-related macular degeneration in humans (corrected for age, sex, BMI, and medications).

    “Diabetes co-existing with hypertension and hyperlipidemia were not shown to be risk factors for the onset of dry AMD.”

    Humanscorrected for age, sex, BMI, and medicationsn = 14,440

    The Influence of Diabetes, Hypertension, and Hyperlipidemia on the Onset of Age-Related Macular Degeneration in North China: The Kailuan Eye Study

    Biomedical and environmental sciences : BES

More on Dry age-related macular degeneration

Cognitive function

downin humans1

1 study
  1. Hyperlipidemia is linked with worse cognitive function in humans (β -0.386, 95% CI -0.70 to -0.02).

    “midlife hyperlipidemia (β [95% CI]: -0.386 [-0.70, -0.02]) were associated with lower verbal episodic memory.”

    Humans

    Impact of Cardiovascular Risk Factors in Adolescence, Young Adulthood, and Midlife on Late-Life Cognition: Study of Healthy Aging in African Americans

    The journals of gerontology. Series A, Biological sciences and medical sciences

Ubiquinol-10

downin humans1

1 study
  1. Hyperlipidemia is linked with lower Ubiquinol-10 in humans (hyperlipidaemic patients vs healthy controls) (P = 0.001 and 0.008).

    “Plasma ubiquinol-10, expressed as a percentage of total ubiquinol-10 + ubiquinone-10 or normalized to plasma lipids, was lower in the patients than in controls”

    Humanshyperlipidaemic patients vs healthy controlsplasma

    Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

    Atherosclerosis

More on Ubiquinol-10

Upstream

3

Niacin

no changein humans1

1 study
  1. Niacin was not clearly linked with hyperlipidemia in nondiabetic participants.

    “no significant association was observed in nondiabetic participants”

    Humansin nondiabetic participants

    Plasma niacin is inversely associated with hyperlipidemia in participants with diabetes among Chinese adults

    Nutrition research (New York, N.Y.)

More on Niacin

FOXO6

upin mice1

1 study
  1. FOXO6 increases hyperlipidemia in mice (shown by knockout).

    “absence of FoxO6 attenuated the expression of genes involved in lipogenesis, resulting in diminished hepatic lipid accumulation and mitigated hyperlipidemia in murine models.”

    Animalsshown by knockout

    FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet

    Aging

More on FOXO6

Time

downin humans1

1 study
  1. time is linked with lower hyperlipidemia in humans (US adults) (40.5% to 36.1%).

    “while the prevalence of hyperlipidemia decreased (from 40.5% [95% CI, 38.6%-42.3%] to 36.1% [95% CI, 33.5%-38.7%]).”

    HumansUS adultsn = 12,924

    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020

    JAMA

Associations

100

Cognitive impairment

upin humans3downin humans2OR 0.47–2.159

5 studies
  1. Hyperlipidemia is linked with a higher risk of cognitive impairment in humans (OR 1.446, p = 0.001).

    “hyperlipidemia (OR: 1.446, p = 0.001) were significantly associated with cognitive impairment positive screening along with prior cognitive impairment disorders diagnosis”

    Humansn = 3,111

    Cognitive impairment among older adults' pilgrims during Hajj: a cross-sectional study of prevalence and associated factors

    BMC geriatrics

  2. Cognitive impairment is associated with hyperlipidemia in humans (Lowest versus highest CERAD-Total score quartile) (OR 2.159, 95% CI 1.161–4.451; P <.001).

    “participants with low cognition (lowest quartile of CERAD-Total score) had significantly greater incidences of hyperlipidemia in comparison to individuals who possessed normal cognitive abilities.”

    HumansLowest versus highest CERAD-Total score quartile

    The causal association between hyperlipidemia and Alzheimer disease: A combined NHANES and Mendelian randomization study

    Medicine

  3. Hyperlipidemia is linked with a lower risk of cognitive impairment in humans (OR = 0.671).

    “hyperlipidemia (OR= 0.671) appears to confer a protective effect against CI.”

    Humansn = 13,027

    Assessing cognitive impairment in home-dwelling Chinese elders aged 80+: a detailed survey of 13,000 participants focusing on demographic factors, social engagement, and disease prevalence

    Frontiers in psychiatry

  4. Hyperlipidemia is linked with a lower risk of cognitive impairment in humans (OR = 0.47, 95% CI = 0.25, 0.89).

    “hyperlipidemia (OR = 0.47, 95% CI = 0.25, 0.89)”

    Humansn = 4,578

    The factors associated with cognitive function among community-dwelling older adults in Taiwan

    BMC geriatrics

  5. Hyperlipidemia is associated with cognitive impairment in humans.

    “hyperlipidemia, disability, lower education level, not regularly involved in technical based activities, limited use of modern technologies”

    Humans

    Predictors of poor cognitive status among older Malaysian adults: baseline findings from the LRGS TUA cohort study

    Aging clinical and experimental research

More on Cognitive impairment

Age-related macular degeneration

upin humans4OR 1.512–5.16

4 studies
  1. Hyperlipidemia is associated with age-related macular degeneration in All of Us validation dataset (OR 5.16, 95% CI 3.76–7.08, P < .05).

    “hyperlipidemia (OR: 5.16, 95% CI: [3.76-7.08], P < .05) showing strong associations with early-onset AMD.”

    Humansin All of Us validation dataset

    Predicting Early Onset of Age-Related Macular Degeneration: A Machine Learning Approach

    American journal of ophthalmology

  2. Hyperlipidemia is linked with a higher risk of age-related macular degeneration in patients with Parkinson's disease (aHR = 1.17, 95% CI: 1.13-1.21).

    “patients with hyperlipidemia (aHR = 1.17, 95% CI: 1.13-1.21)”

    Humansin patients with Parkinson's disease

    Incidence and risk factors of age-related macular degeneration in patients with Parkinson's disease: a population-based study

    Frontiers in aging neuroscience

  3. Hyperlipidemia is linked with a higher risk of age-related macular degeneration in humans (adjusted HR 1.40, 95% CI 1.20-1.63, p < 0.001).

    “Additionally, the adjusted HR of AMD for study group II was 1.40 (95% CI = 1.20-1.63, p < 0.001) relative to the comparison group (n = 61,928).”

    Humanspatients not receiving antihyperlipidemic agents relative to comparison group without hyperlipidemia

    Association between Antihyperlipidemic Agent Use and Age-Related Macular Degeneration in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study

    Biomedicines

  4. Hyperlipidemia raises the risk of age-related macular degeneration in Iran (OR 1.512, 95% CI 1.055-2.165).

    “hyperlipidemia (OR: 1.512; 95% CI: 1.055-2.165) were identified as AMD risk factors.”

    Reviewin Iran

    Age-Related Macular Degeneration Prevalence and its Risk Factors in Iran: A Systematic Review and Meta-Analysis Study

    Journal of current ophthalmology

More on Age-related macular degeneration

Hypertension

upin humans3

3 studies
  1. Hyperlipidemia is associated with hypertension in humans (older adults).

    “Hyperlipidemia, diabetes, basal metabolic rate, body muscle percentage, body fat percentage, average daily step count, stress, heartrate, and depression influenced HYP among older adults.”

    Humansolder adultsn = 3,214

    Machine-learning-based risk assessment of hypertension among older adults in Korea

    Digital health

  2. Hyperlipidemia is associated with hypertension in humans (multiple chronic conditions) (4.7%-7.3% co-occurrence alone, 65.1%-88.0% with other conditions).

    “The most common profile across sex and racial and ethnic groups was co-occurring hypertension and hyperlipidemia”

    Humansmultiple chronic conditions

    Descriptive Epidemiology of New York City Older Adult Patients With Multiple Chronic Conditions

    Preventing chronic disease

  3. Hyperlipidemia is linked with a higher risk of hypertension in humans (early rheumatoid arthritis).

    “Baseline factors significantly associated with incident HTN were older age, being overweight, excess alcohol consumption and having hyperlipidaemia.”

    Humansearly rheumatoid arthritismedian follow-up period of 5 yearsn = 1,518

    Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort

    Rheumatology advances in practice

More on Hypertension

Mild cognitive impairment

upin humans2downin humans1OR 0.45–1.94

3 studies
  1. Hyperlipidemia is linked with a higher risk of mild cognitive impairment in humans (later life) (OR 1.94, 95% CI 1.09–3.48).

    “In later life, the odds of MCI classification are nearly doubled in individuals with HLD(OR=1.94, 95%CI=1.09–3.48, p = 0.024)”

    Humanslater life

    Impact of Vascular Risk Burden and ApoE4 on Cognitive Impairment: Insights from a Non‐Demented Southeast Asian Population

    AAIC 2025 abstract

  2. Hyperlipidemia is linked with a lower risk of mild cognitive impairment in humans (OR = 0.45, 95% CI = 0.22-0.96).

    “the prevalence of MCI was lower in older women with high grip strength (OR = 0.96, 95% CI = 0.92-0.99) and hyperlipidemia (OR = 0.45, 95% CI = 0.22-0.96).”

    Humansfemalesn = 768

    Gender-specific prevalence and risk factors of mild cognitive impairment among older adults in Chongming, Shanghai, China

    Frontiers in aging neuroscience

  3. Hyperlipidemia is linked with a higher risk of mild cognitive impairment in patients with hypertension (OR=1.49, 95% CI 1.01-2.16).

    “Hyperlipidemia (OR=1.49, 95%=1.01-2.16)”

    Humansin patients with hypertension

    The relationship between the status of hypertension and lifestyle risk factors in middle-aged and elderly patients with mild cognitive impairment: a case-control study

    Research SquarePreprint

More on Mild cognitive impairment

Hysterectomy

upin humans2HR 1.21

2 studies
  1. Hysterectomy is linked with a higher risk of hyperlipidemia in humans (compared to myomectomy in patients with uterine fibroids) (aOR = 1.26).

    “Hysterectomy was associated with higher age-adjusted odds of developing hyperlipidemia (aOR = 1.26) compared to myomectomy.”

    Humanscompared to myomectomy in patients with uterine fibroids10 yearsfemalesn = 34,722

    Improved Cardiometabolic Health with Uterine-Preserving Fibroid Treatment Compared to Hysterectomy

    Journal of clinical medicine

  2. Hysterectomy is associated with hyperlipidemia in humans (HR 1.21, 95% CI 1.13–1.29).

    “hyperlipidemia (hazard ratio 1.21, 95% confidence interval 1.13-1.29)”

    Reviewfemales

    Decision for hysterectomy as a modifiable cardiovascular risk factor: A systematic review and meta-analysis

    medRxivPreprint

More on Hysterectomy

Chronic kidney disease

upin humans2OR 2.33

2 studies
  1. Chronic kidney disease is associated with hyperlipidemia in humans (Adults with versus without chronic kidney disease) (OR 2.33, 95% CI 2.25-2.40; prevalence 61.8% versus 41.0%).

    “hyperlipidemia (61.8% vs. 41.0%; OR 2.33, 95% CI 2.25-2.40)”

    HumansAdults with versus without chronic kidney diseasen = 327,671

    Cardiometabolic Multimorbidity in United States Adults with Chronic Kidney Disease: A Nationally Representative Cross-Sectional Study

    AHA Scientific Sessions 2026 abstract

  2. Chronic kidney disease is linked with a higher risk of hyperlipidemia in humans (PLWH).

    “BMI ≥24.0 kg/m2, HDL-C <40 and CKD increased the risks for hyperlipidemia.”

    HumansPLWH

    Cardiometabolic multimorbidity in aging adults with HIV: Real-world evidence from a care cohort in Taiwan

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

More on Chronic kidney disease

Atherosclerotic cardiovascular disease

upin humans2OR 3.36

2 studies
  1. Hyperlipidemia is linked with a higher risk of atherosclerotic cardiovascular disease in humans (OR: 3.36, 95% CI: 3.13-3.61).

    “Hyperlipidemia (OR: 3.36; 95% CI: 3.13-3.61) and hypertension (OR: 3.14; 95% CI: 2.91-3.39) were the strongest correlates of ASCVD”

    Humansn = 49,440

    Cardiometabolic and ASCVD Risk Profiles in Arab Americans: Insights From the SALAM Registry

    JACC. Advances

  2. Hyperlipidemia is associated with atherosclerotic cardiovascular disease in humans (1 year after COPD hospitalization).

    “hyperlipidemia and history of acute ASCVD event were associated with the highest risk of ASCVD events 1 year after COPD hospitalization”

    Humans1 year after COPD hospitalization1 year

    Risk of Atherosclerotic Cardiovascular Disease After Chronic Obstructive Pulmonary Disease Hospitalization among Primary and Secondary Prevention Older Adults

    Journal of the American Heart Association

More on Atherosclerotic cardiovascular disease

Magnesium

mixedin humans1downin humans1OR 0.68

2 studies
  1. Magnesium is associated with hyperlipidemia in humans (cross-sectional analysis in adults).

    “a V-shaped non-linear association with hyperlipidemia”

    Humanscross-sectional analysis in adultsplasman = 1,429

    Association between plasma magnesium levels and glycolipid metabolism in a southern Chinese population: a cross-sectional study in Shenzhen

    Frontiers in endocrinology

  2. Magnesium is associated with hyperlipidemia in humans (OR 0.68 (95% CI: 0.53-0.86)).

    “the OR of hyperlipidemia was 0.68 (95% confidence interval: 0.53-0.86; P trend = 0.007)”

    Humanshighest vs lowest quintile of dietary magnesium intake, adjusted for sociodemographic, anthropometric and lifestyle factorsn = 12,149

    Associations between dietary magnesium intake and hypertension, diabetes, and hyperlipidemia

    Hypertension research : official journal of the Japanese Society of Hypertension

More on Magnesium

Body mass index

upin humans2

2 studies
  1. Body mass index is linked with a higher risk of hyperlipidemia in humans (middle-aged and older adult individuals in China) (OR > 1, p < 0.05).

    “Body Mass Index (BMI), fasting blood glucose, serum uric acid, C-reactive protein, and white blood cell count were independent risk factors for hyperlipidemia in this demographic (with Odds Ratios (OR) greater than 1 and p-values less than 0.05).”

    Humansmiddle-aged and older adult individuals in Chinan = 6,629

    Development and validation of a hyperlipidemia risk prediction model for middle-aged and older adult Chinese using 2015 CHARLS data

    Frontiers in public health

  2. Body mass index predicts hyperlipidemia in humans.

    “Body mass index performed better in predicting hyperlipidemia in women.”

    Humansfemalesn = 1,990

    Predictive values of relative fat mass and body mass index on cardiovascular health in community-dwelling older adults: Results from the Longevity Check-up (Lookup) 7

    Maturitas

More on Body mass index

Diabetes mellitus

upin humans2

2 studies
  1. Hyperlipidemia is linked with a higher risk of diabetes mellitus in humans (χ21=47.671; P<.001).

    “Hyperlipidemia and higher heart rates further heightened diabetes probability.”

    Humans

    AI Machine Learning-Based Diabetes Prediction in Older Adults in South Korea: Cross-Sectional Analysis

    JMIR formative research

  2. Diabetes mellitus is associated with hyperlipidemia in humans (p<0.001).

    “Visual impairment (p<0.01), hypertension (p<0.001) and hyperlipidemia (p<0.001) were more frequent among those with diabetes.”

    Humans

    Prevalence of Diabetes Among Community-Living Older Persons in the Philippines: The FITforFrail Study

    Journal of the ASEAN Federation of Endocrine Societies

More on Diabetes mellitus

All 100

Trial sponsors

Funding

5 grants since 2016

National Heart, Lung, and Blood Institute$1.3MNational Institute of Arthritis and Musculoskeletal and Skin Diseases$685KVetenskapsrådetSEK 2.1M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Hyperlipidemia is linked with higher age-related macular degeneration risk in people with Parkinson’s disease, while a human study finds no clear link with dry age-related macular degeneration. Human studies associate it with higher mild cognitive impairment risk in later life but lower risk in women. A rat study reports that hyperlipidemia induces cellular senescence in cartilage endplates.

  2. Summary rewritten as its findings changed.

    As it read before

    Hyperlipidemia is linked with coronary artery disease in women, age-related macular degeneration in people with Parkinson's disease, and frailty in people with stroke. Human observational studies report differing cognitive associations: higher mild cognitive impairment risk in later life or in people with hypertension, but lower risk in women. A rat study reports that hyperlipidemia induces cartilage endplate cellular senescence.

  3. Summary rewritten as its findings changed.

    As it read before

    Human observational studies link hyperlipidemia with age-related macular degeneration and atherosclerotic cardiovascular disease, while a study of dry macular degeneration reports no clear link. Cognitive impairment associations point both ways across human studies. A rat study reports that hyperlipidemia induces cellular senescence in the cartilage endplate.

  4. Summary rewritten as its findings changed.

    As it read before

    Human observational studies associate police work and software engineering with hyperlipidemia, and intuitive eating with lower hyperlipidemia risk after adjustment for age, sex and race/ethnicity. Another human study associates hyperlipidemia with increased atherosclerotic cardiovascular disease risk.

  5. Summary written from the findings.

Latest

Dec 2025: 50Jan 2026: 45Feb 2026: 46Mar 2026: 32Apr 2026: 20May 2026: 21Jun 2026: 19Jul 2026: 17Aug 2026: 25Sep 2026: 28Oct 2026: 58Nov 2026: 55416 papers in 12 months
Gut Microbes

Gut bacterial product changes blood fat levels in mice

Mice given a bile acid made by the gut bacterium Ruminococcus gnavus developed blood fat disturbances.Mice given a bile acid made by the gut bacterium Ruminococcus gnavus developed blood fat disturbances.

Mouse studyMechanisms
AHA Scientific Sessions 2026 Abstract

Day-shift work linked to fewer major cardiovascular events

Compared with other schedules, day-shift work was linked to a lower relative rate of major cardiovascular events—a hazard ratio of 0.78 over a median 3.3 years.Compared with other schedules, day-shift work was linked to a lower relative rate of major cardiovascular events—a hazard ratio of 0.78 over a median 3.3 years.

Cohort · 42,429 peoplePopulations

See all 1,215 papers on hyperlipidemia